ImmunityBio (IBRX) Cash & Equivalents Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 36.53% |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn | 32.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.36% |
| Dec 31, 2025 | -5.49% |
| Sep 30, 2025 | -16.68% |
| Jun 30, 2025 | 30.53% |
| Mar 31, 2025 | 18.58% |
| Dec 31, 2024 | -7.48% |
| Sep 30, 2024 | 20.17% |
| Jun 30, 2024 | 15.72% |
| Mar 31, 2024 | 43.86% |
| Dec 31, 2023 | 96.63% |
| Sep 30, 2023 | 28.09% |
| Jun 30, 2023 | -27.71% |
| Mar 31, 2023 | 14.69% |
| Dec 31, 2022 | 11.35% |
| Sep 30, 2022 | 78.58% |
| Jun 30, 2022 | 53.01% |
| Mar 31, 2022 | 17.76% |
| Dec 31, 2021 | 120.81% |
| Sep 30, 2021 | 61.53% |
| Jun 30, 2021 | 73.33% |
| Mar 31, 2021 | 58.62% |
| Dec 31, 2020 | 13.51% |
| Sep 30, 2020 | 73.83% |
| Jun 30, 2020 | 43.42% |
| Mar 31, 2020 | 62.79% |
| Dec 31, 2019 | 110.88% |
| Sep 30, 2019 | -16.49% |
| Jun 30, 2019 | -23.25% |
| Mar 31, 2019 | -29.38% |
| Dec 31, 2018 | -54.27% |
| Sep 30, 2018 | -65.05% |
| Jun 30, 2018 | -48.85% |
| Mar 31, 2018 | -39.22% |
| Dec 31, 2017 | -26.08% |
| Sep 30, 2017 | 71.81% |
| Jun 30, 2017 | 113.85% |
| Dec 31, 2016 | 184.77% |